COVID-19 glycoproteomic analysis with OxoScan
Import OxoScan output for COVID-19 cohort
## [1] "1102 glycopeptide features called and quantified across Kuebler cohort"
Checkpoint - peaks quantified by OxoScan across cohort:
## [1] "1002 features taken forward following interference filtering"
## [1] "567 features quantified robustly (median CV < 20%) across clinical cohort"
## [1] "99.43% of features with retention time shift below 12s"
Hierarchical Clustering by Glycoproteome

Matching DDA-identified glycopeptides to OxoScan-quantified features
Identifying glycopeptide precursors with MS1/Q1 overlay spectra, back-to-back CID/HCD spectra comparison and OxoScan quantification for each feature

## [1] "66 started"
## [1] "66 done"
## [1] "98 started"
## [1] "98 done"
## [1] "203 started"
## [1] "203 done"
## [1] "8 started"
## [1] "8 done"
## [1] "11 started"
## [1] "11 done"
## [1] "499 started"
## [1] "499 done"
## [1] "20 started"
## [1] "20 done"
## [1] "1 started"
## [1] "1 done"
## [1] "3 started"
## [1] "3 done"
## [1] "292 started"
## [1] "292 done"
## [1] "125 started"
## [1] "125 done"
## [1] "23 started"
## [1] "23 done"
## [1] "19 started"
## [1] "19 done"
## [1] "73 started"
## [1] "73 done"
## [1] "172 started"
## [1] "172 done"
## [1] "50 started"
## [1] "50 done"
## [1] "130 started"
## [1] "130 done"
## [1] "40 started"
## [1] "40 done"
## [1] "28 started"
## [1] "28 done"
## [1] "16 started"
## [1] "16 done"
## [1] "142 started"
## [1] "142 done"
## [1] "39 started"
## [1] "39 done"
## [1] "5 started"
## [1] "5 done"
## [1] "26 started"
## [1] "26 done"
## [1] "12 started"
## [1] "12 done"
